AffaMed Therapeutics
Roger Liu has extensive work experience in the field of clinical operations and research. Roger has held various roles in different companies throughout their career.
In 2022, Roger Liu joined AffaMed Therapeutics as the Director of Clinical Operations. Prior to this, from 2018 to 2022, they worked at Beijing Fosun Pharmaceutical Research and Development Co., Ltd. as a Director.
From 2015 to 2018, Roger Liu served as a GM at Win-Sea Capital. Before that, in 2014, they were the Clinical Research Business Unit Director at Jsure Health.
From 2013 to 2014, Roger Liu worked as the SMO BU Director at Shanghai Chencheng Medical Development Co., Ltd.
Earlier in their career, from 2012 to 2013, they worked as a Clinical Research Manager at Abbott EPD China. In 2011, Roger Liu was the Associate Director of the External Affairs Department at rundo-cronova.
From 2005 to 2011, they served as a CPM at xi'an Janssen company.
Roger Liu started their career in 1997 as a Technician at Wuhu Sanyi company and worked there until 2001.
Roger Liu earned a Bachelor's degree in Pharmacy from Anhui Medical University from 1993-1997. Roger then pursued an MBA at Fudan University from 2003-2005.
AffaMed Therapeutics
AffaMed Therapeutics is a clinical stage therapeutic company focused on developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmic, neurological and psychiatric disorders for patients in Greater China and around the world. The leadership team of AffaMed Therapeutics has gained deep industry expertise and an extensive track record in high-quality discovery, clinical development, regulatory affairs, manufacturing, commercial operations, and business development at leading multi-national pharmaceutical companies in China and globally.